Right ventricular failure and pathobiology in patients with congenital heart disease - implications for long-term follow-up

Frontiers in Pediatrics

Volumn 1, Issue NOV, 2013, Pages

  Köhler, Doreen ^a   Arnold, Raoul ^a   Loukanov, Tsvetomir ^a   Gorenflo, Matthias ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Congenital heart defects; Imaging; Pathobiology; Right ventricle; Surgical techniques

Indexed keywords

EID: 84911462933     PISSN: None     EISSN: 22962360     Source Type: Journal    
DOI: 10.3389/fped.2013.00037     Document Type: Review

References (87)

1. Therrien J, Siu SC, Harris L, Dore A, Niwa K, Janousek J, et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation (2001) 103(20):2489-94. doi:10.1161/01.CIR.103.20.2489
2. Khairy P, Fernandes SM, Mayer JE Jr, Triedman JK, Walsh EP, Lock JE, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation (2008) 117(1):85-92. doi:10.1161/CIRCULATIONAHA.107.738559
3. Gelatt M, Hamilton RM, McCrindle BW, Connelly M, Davis A, Harris L, et al. Arrhythmia and mortality after the mustard procedure: a 30-year single-center experience. J Am Coll Cardiol (1997) 29(1):194-201. doi:10.1016/S0735-1097(96)00424-X
4. Roos-Hesselink JW, Meijboom FJ, Spitaels SE, van Domburg R, van Rijen EH, Utens EM, et al. Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22-29 years). Eur Heart J (2004) 25(14):1264-70. doi:10.1016/j.ehj.2004.03.009
5. Sarkar D, Bull C, Yates R, Wright D, Cullen S, Gewillig M, et al. Comparison of long-term outcomes of atrial repair of simple transposition with implications for a late arterial switch strategy. Circulation (1999) 100(19 Suppl):II176-81. doi:10.1161/01.CIR.100.suppl_2.II-176
6. Dinardo JA. Heart failure associated with adult congenital heart disease. Semin Cardiothorac Vasc Anesth (2013) 17(1):44-54. doi:10.1177/1089253212469841
7. Norozi K, Wessel A, Alpers V, Arnhold JO, Geyer S, Zoege M, et al. Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery. Am J Cardiol (2006) 97(8):1238-43. doi:10.1016/j.amjcard.2005.10.065
8. Anderson PA, Sleeper LA, Mahony L, Colan SD, Atz AM, Breitbart RE, et al. Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network Multicenter Study. J Am Coll Cardiol (2008) 52(2):85-98. doi:10.1016/j.jacc.2008.01.074
9. Cecchin F, Frangini PA, Brown DW, Fynn-Thompson F, Alexander ME, Triedman JK, et al. Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution. J Cardiovasc Electrophysiol (2009) 20(1):58-65. doi:10.1111/j.1540-8167.2008.01274.x
10. Dubin AM, Janousek J, Rhee E, Strieper MJ, Cecchin F, Law IH, et al. Resynchronization therapy in pediatric and congenital heart disease patients an international multicenter study. J Am Coll Cardiol (2005) 46(12):2277-83. doi:10.1016/j.jacc.2005.05.096
11. Files MD, Boucek RJ. 'Shovel-ready' applications of stem cell advances for pediatric heart disease. Curr Opin Pediatr (2012) 24(5):577-83. doi:10.1097/MOP.0b013e328357a4cf
12. Pincott ES, Burch M. Potential for stem cell use in congenital heart disease. Future Cardiol (2012) 8(2):161-9. doi:10.2217/fca.12.13
13. Rupp S, Zeiher AM, Dimmeler S, Tonn T, Bauer J, Jux C, et al. A regenerative strategy for heart failure in hypoplastic left heart syndrome: intracoronary administration of autologous bone marrow-derived progenitor cells. J Heart Lung Transplant (2010) 29(5):574-7. doi:10.1016/j.healun.2009.10.006
14. Rupp S, Bauer J, Tonn T, Schachinger V, Dimmeler S, Zeiher AM, et al. Intracoronary administration of autologous bone marrow-derived progenitor cells in a critically ill two-yr-old child with dilated cardiomyopathy. Pediatr Transplant (2009) 13(5):620-3. doi:10.1111/j.1399-3046.2008.01024.x
15. van der Bom T, Winter MM, Groenink M, Vliegen HW, Pieper PG, van Dijk AP, et al. Right ventricular end-diastolic volume combined with peak systolic blood pressure during exercise identifies patients at risk of complications in adults with a systemic right ventricle. J Am Coll Cardiol (2013) 62(10):926-36. doi:10.1016/j.jacc.2013.06.026
16. Sheehan F, Redington A. The right ventricle: anatomy, physiology and clinical imaging. Heart (2008) 94(11):1510-5. doi:10.1136/hrt.2007.132779
17. Brookes C, Ravn H, White P, Moeldrup U, Oldershaw P, Redington A. Acute right ventricular dilatation in response to ischemia significantly impairs left ventricular systolic performance. Circulation (1999) 100(7):761-7. doi:10.1161/01.CIR.100.7.761
18. Abd El Rahman MY, Hui W, Schuck R, Rentzsch A, Berger F, Gutberlet M, et al. Regional analysis of longitudinal systolic function of the right ventricle after corrective surgery of tetralogy of Fallot using myocardial isovolumetric acceleration index. Pediatr Cardiol (2013) 34(8):1848-53. doi:10.1007/s00246-013-0726-0
19. Koca B, Oztunc F, Eroglu AG, Gokalp S, Dursun M, Yilmaz R. Evaluation of right ventricular function in patients with tetralogy of Fallot using the myocardial performance index and isovolumic acceleration: a comparison with cardiac magnetic resonance imaging. Cardiol Young (2013). doi:10.1017/S1047951113000504
20. Koestenberger M, Nagel B, Avian A, Ravekes W, Sorantin E, Cvirn G, et al. Systolic right ventricular function in children and young adults with pulmonary artery hypertension secondary to congenital heart disease and tetralogy of Fallot: tricuspid annular plane systolic excursion (TAPSE) and magnetic resonance imaging data. Congenit Heart Dis (2012) 7(3):250-8. doi:10.1111/j.1747-0803.2012.00655.x
21. Mercer-Rosa L, Parnell A, Forfia PR, Yang W, Goldmuntz E, Kawut SM. Tricuspid annular plane systolic excursion in the assessment of right ventricular function in children and adolescents after repair of tetralogy of Fallot. J Am Soc Echocardiogr (2013) 26(11):1322-9. doi:10.1016/j.echo.2013.06.022
22. Dragulescu A, Grosse-Wortmann L, Fackoury C, Mertens L. Echocardiographic assessment of right ventricular volumes: a comparison of different techniques in children after surgical repair of tetralogy of Fallot. Eur Heart J Cardiovasc Imaging (2012) 13(7):596-604. doi:10.1093/ejechocard/jer278
23. Husain N, Gokhale J, Nicholson L, Cheatham JP, Holzer RJ, Cua CL. Noninvasive estimation of ventricular filling pressures in patients with single right ventricles. J Am Soc Echocardiogr (2013) 26(11):1330-6. doi:10.1016/j.echo.2013.08.002
24. Osterholt M, Sen S, Dilsizian V, Taegtmeyer H. Targeted metabolic imaging to improve the management of heart disease. JACC Cardiovasc Imaging (2012) 5(2):214-26. doi:10.1016/j.jcmg.2011.11.009
25. Al Habib HF, Jacobs JP, Mavroudis C, Tchervenkov CI, O'Brien SM, Mohammadi S, et al. Contemporary patterns of management of tetralogy of Fallot: data from the society of thoracic surgeons database. Ann Thorac Surg (2010) 90(3):813-9. doi:10.1016/j.athoracsur.2010.03.110
26. Bove EL, Byrum CJ, Thomas FD, Kavey RE, Sondheimer HM, Blackman MS, et al. The influence of pulmonary insufficiency on ventricular function following repair of tetralogy of Fallot. Evaluation using radionuclide ventriculography. J Thorac Cardiovasc Surg (1983) 85(5):691-6
27. Zahka KG, Horneffer PJ, Rowe SA, Neill CA, Manolio TA, Kidd L, et al. Long-term valvular function after total repair of tetralogy of Fallot. Relation to ventricular arrhythmias. Circulation (1988) 78(5 Pt 2):III14-9
28. Bouzas B, Kilner PJ, Gatzoulis MA. Pulmonary regurgitation: not a benign lesion. Eur Heart J (2005) 26(5):433-9. doi:10.1093/eurheartj/ehi091
29. Therrien J, Siu SC, McLaughlin PR, Liu PP, Williams WG, Webb GD. Pulmonary valve replacement in adults late after repair of tetralogy of Fallot: are we operating too late? J Am Coll Cardiol (2000) 36(5):1670-5. doi:10.1016/S0735-1097(00)00930-X
30. Geva T. Indications and timing of pulmonary valve replacement after tetralogy of Fallot repair. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu (2006) 9(1):11-22
31. Forbess JM. Conduit selection for right ventricular outflow tract reconstruction: contemporary options and outcomes. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu (2004) 7:115-24. doi:10.1053/j.pcsu.2004.02.004
32. Perri G, Polito A, Esposito C, Albanese SB, Francalanci P, Pongiglione G, et al. Early and late failure of tissue-engineered pulmonary valve conduits used for right ventricular outflow tract reconstruction in patients with congenital heart disease. Eur J Cardiothorac Surg (2012) 41(6):1320-5. doi:10.1093/ejcts/ezr221
33. Nakayama Y, Yahata Y, Yamanami M, Tajikawa T, Ohba K, Kanda K, et al. A completely autologous valved conduit prepared in the open form of trileaflets (type VI biovalve): mold design and valve function in vitro. J Biomed Mater Res B Appl Biomater (2011) 99(1):135-41. doi:10.1002/jbm.b.31880
34. Takewa Y, Yamanami M, Kishimoto Y, Arakawa M, Kanda K, Matsui Y, et al. In vivo evaluation of an in-body, tissue-engineered, completely autologous valved conduit (biovalve type VI) as an aortic valve in a goat model. J Artif Organs (2013) 16(2):176-84. doi:10.1007/s10047-012-0679-8
35. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The registry of the international society for heart and lung transplantation: seventeenth official report-2000. J Heart Lung Transplant (2000) 19(10):909-31. doi:10.1016/S1053-2498(00)00138-8
36. Bajona P, Salizzoni S, Brann SH, Coyne J, Bermudez C, Kormos R, et al. Prolonged use of right ventricular assist device for refractory graft failure following orthotopic heart transplantation. J Thorac Cardiovasc Surg (2010) 139(3):e53-4. doi:10.1016/j.jtcvs.2008.10.042
37. Hodge AB, Yeager CJ, Preston TJ, Savage AJ, Butts RJ, Kavarana MN. The Thoratec CentriMag for pediatric right ventricular failure. J Extra Corpor Technol (2013) 45(2):133-5
38. Tang D, Yang C, Geva T, Rathod R, Yamauchi H, Gooty V, et al. A multiphysics modeling approach to develop right ventricle pulmonary valve replacement surgical procedures with a contracting band to improve ventricle ejection fraction. Comput Struct (2013) 122:78-87. doi:10.1016/j.compstruc.2012.11.016
39. Bogaard HJ, Abe K, Vonk Noordegraaf A, Voelkel NF. The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest (2009) 135(3):794-804. doi:10.1378/chest.08-0492
40. Mann DL. Basic mechanisms of left ventricular remodeling: the contribution of wall stress. J Card Fail (2004) 10(6 Suppl):S202-6. doi:10.1016/j.cardfail.2004.09.008
41. Katsumi A, Orr AW, Tzima E, Schwartz MA. Integrins in mechanotransduction. J Biol Chem (2004) 279(13):12001-4. doi:10.1074/jbc.R300038200
42. Ross RS, Pham C, Shai SY, Goldhaber JI, Fenczik C, Glembotski CC, et al. Beta1 integrins participate in the hypertrophic response of rat ventricular myocytes. Circ Res (1998) 82(11):1160-72. doi:10.1161/01.RES.82.11.1160
43. Kuwahara K, Nishikimi T, Nakao K. Transcriptional regulation of the fetal cardiac gene program. J Pharmacol Sci (2012) 119(3):198-203. doi:10.1254/jphs.12R04CP
44. Azakie A, Fineman J, He Y. Differential responses of the right ventricle to abnormal loading conditions in vivo: possible pathophysiologic mechanisms. J Thorac Cardiovasc Surg (2013) 145(5):1335-44. doi:10.1016/j.jtcvs.2013.01.016
45. Reddy S, Zhao M, Hu DQ, Fajardo G, Katznelson E, Punn R, et al. Physiologic and molecular characterization of a murine model of right ventricular volume overload. Am J Physiol Heart Circ Physiol (2013) 304(10):H1314-27. doi:10.1152/ajpheart.00776.2012
46. Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Quaife RA, et al. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest (1997) 100(9):2315-24. doi:10.1172/JCI119770
47. Herron TJ, McDonald KS. Small amounts of alpha-myosin heavy chain isoform expression significantly increase power output of rat cardiac myocyte fragments. Circ Res (2002) 90(11):1150-2. doi:10.1161/01.RES.0000022879.57270.11
48. Adamcova M, Sterba M, Simunek T, Potacova A, Popelova O, Mazurova Y, et al. Troponin as a marker of myocardiac damage in drug-induced cardiotoxicity. Expert Opin Drug Saf (2005) 4(3):457-72. doi:10.1517/14740338.4.3.457
49. VanBuren P, Okada Y. Thin filament remodeling in failing myocardium. Heart Fail Rev (2005) 10(3):199-209. doi:10.1007/s10741-005-5250-8
50. Janicki JS, Brower GL, Gardner JD, Forman MF, Stewart JA Jr, Murray DB, et al. Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload. Cardiovasc Res (2006) 69(3):657-65. doi:10.1016/j.cardiores.2005.10.020
51. Baicu CF, Stroud JD, Livesay VA, Hapke E, Holder J, Spinale FG, et al. Changes in extracellular collagen matrix alter myocardial systolic performance. Am J Physiol Heart Circ Physiol (2003) 284(1):H122-32. doi:10.1152/ajpheart.00233.2002
52. Khan R, Sheppard R. Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia. Immunology (2006) 118(1):10-24. doi:10.1111/j.1365-2567.2006.02336.x
53. Weber KT, Pick R, Janicki JS, Gadodia G, Lakier JB. Inadequate collagen tethers in dilated cardiopathy. Am Heart J (1988) 116(6 Pt 1):1641-6. doi:10.1016/0002-8703(88)90763-6
54. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest (2005) 115(3):500-8. doi:10.1172/JCI24408
55. Yet SF, Perrella MA, Layne MD, Hsieh CM, Maemura K, Kobzik L, et al. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest (1999) 103(8):R23-9. doi:10.1172/JCI6163
56. Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res (2002) 91(11):988-98. doi:10.1161/01.RES.0000043825.01705.1B
57. Jobe LJ, Melendez GC, Levick SP, Du Y, Brower GL, Janicki JS. TNF-alpha inhibition attenuates adverse myocardial remodeling in a rat model of volume overload. Am J Physiol Heart Circ Physiol (2009) 297(4):H1462-8. doi:10.1152/ajpheart.00442.2009
58. Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, Lee RT. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest (2007) 117(6):1538-49. doi:10.1172/JCI30634
59. Weinberg EO, Shimpo M, Hurwitz S, Tominaga S, Rouleau JL, Lee RT. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation (2003) 107(5):721-6. doi:10.1161/01.CIR.0000047274.66749.FE
60. Zhang YH, Dingle L, Hall R, Casadei B. The role of nitric oxide and reactive oxygen species in the positive inotropic response to mechanical stretch in the mammalian myocardium. Biochim Biophys Acta (2009) 1787(7):811-7. doi:10.1016/j.bbabio.2009.03.020
61. van Wolferen SA, Marcus JT, Westerhof N, Spreeuwenberg MD, Marques KM, Bronzwaer JG, et al. Right coronary artery flow impairment in patients with pulmonary hypertension. Eur Heart J (2008) 29(1):120-7. doi:10.1093/eurheartj/ehm567
62. Tomanek RJ. Response of the coronary vasculature to myocardial hypertrophy. J Am Coll Cardiol (1990) 15(3):528-33. doi:10.1016/0735-1097(90)90620-5
63. Partovian C, Adnot S, Eddahibi S, Teiger E, Levame M, Dreyfus P, et al. Heart and lung VEGF mRNA expression in rats with monocrotaline-or hypoxia-induced pulmonary hypertension. Am J Physiol (1998) 275(6 Pt 2):H1948-56
64. Soonpaa MH, Field LJ. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res (1998) 83(1):15-26. doi:10.1161/01.RES.83.1.15
65. Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation (2003) 107(7):984-91. doi:10.1161/01.CIR.0000051865.66123.B7
66. Braun MU, Szalai P, Strasser RH, Borst MM. Right ventricular hypertrophy and apoptosis after pulmonary artery banding: regulation of PKC isozymes. Cardiovasc Res (2003) 59(3):658-67. doi:10.1016/S0008-6363(03)00470-X
67. Wencker D, Chandra M, Nguyen K, Miao W, Garantziotis S, Factor SM, et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest (2003) 111(10):1497-504. doi:10.1172/JCI17664
68. Yaoita H, Ogawa K, Maehara K, Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation (1998) 97(3):276-81. doi:10.1161/01.CIR.97.3.276
69. Holly TA, Drincic A, Byun Y, Nakamura S, Harris K, Klocke FJ, et al. Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo. J Mol Cell Cardiol (1999) 31(9):1709-15. doi:10.1006/jmcc.1999.1006
70. Drake JI, Bogaard HJ, Mizuno S, Clifton B, Xie B, Gao Y, et al. Molecular signature of a right heart failure program in chronic severe pulmonary hypertension. Am J Respir Cell Mol Biol (2011) 45(6):1239-47. doi:10.1165/rcmb.2010-0412OC
71. Haddad F, Ashley E, Michelakis ED. New insights for the diagnosis and management of right ventricular failure, from molecular imaging to targeted right ventricular therapy. Curr Opin Cardiol (2010) 25(2):131-40. doi:10.1097/HCO.0b013e328335febd
72. Mathiyalagan P, Chang L, Du XJ, El-Osta A. Cardiac ventricular chambers are epigenetically distinguishable. Cell Cycle (2010) 9(3):612-7. doi:10.4161/cc.9.3.10612
73. Friehs I, Cowan DB, Choi YH, Black KM, Barnett R, Bhasin MK, et al. Pressure-overload hypertrophy of the developing heart reveals activation of divergent gene and protein pathways in the left and right ventricular myocardium. Am J Physiol Heart Circ Physiol (2013) 304(5):H697-708. doi:10.1152/ajpheart.00802.2012
74. van Rooij E, Olson EN. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest (2007) 117(9):2369-76. doi:10.1172/JCI33099
75. Archer SL, Weir EK, Wilkins MR. Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies. Circulation (2010) 121(18):2045-66. doi:10.1161/CIRCULATIONAHA.108.847707
76. Agger P, Hyldebrandt JA, Nielsen EA, Hjortdal V, Smerup M. A novel porcine model for right ventricular dilatation by external suture plication of the pulmonary valve leaflets-practical and reproducible. Interact Cardiovasc Thorac Surg (2010) 10(6):962-6. doi:10.1510/icvts.2009.227264
77. Yerebakan C, Klopsch C, Niefeldt S, Zeisig V, Vollmar B, Liebold A, et al. Acute and chronic response of the right ventricle to surgically induced pressure and volume overload-an analysis of pressure-volume relations. Interact Cardiovasc Thorac Surg (2010) 10(4):519-25. doi:10.1510/icvts.2009.221234
78. Sutendra G, Dromparis P, Paulin R, Zervopoulos S, Haromy A, Nagendran J, et al. A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension. J Mol Med (Berl) (2013) 91(11):1315-27. doi:10.1007/s00109-013-1059-4
79. Drake JI, Gomez-Arroyo JG, Dumur CI, Kraskauskas D, Natarajan R, Bogaard HJ, et al. Chronic carvedilol treatment partially reverses the right ventricular failure transcriptional profile in experimental pulmonary hypertension. Physiol Genomics (2013) 45(12):449-61. doi:10.1152/physiolgenomics.00166.2012
80. Bogaard HJ, Mizuno S, Hussaini AA, Toldo S, Abbate A, Kraskauskas D, et al. Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats. Am J Respir Crit Care Med (2011) 183(10):1402-10. doi:10.1164/rccm.201007-1106OC
81. Kreymborg K, Uchida S, Gellert P, Schneider A, Boettger T, Voswinckel R, et al. Identification of right heart-enriched genes in a murine model of chronic outflow tract obstruction. J Mol Cell Cardiol (2010) 49(4):598-605. doi:10.1016/j.yjmcc.2010.07.014
82. Kim KH, Kim YJ, Lee SP, Kim HK, Seo JW, Sohn DW, et al. Survival, exercise capacity, and left ventricular remodeling in a rat model of chronic mitral regurgitation: serial echocardiography and pressure-volume analysis. Korean Circ J (2011) 41(10):603-11. doi:10.4070/kcj.2011.41.10.603
83. Rajagopalan V, Zhao M, Reddy S, Fajardo GA, Wang X, Dewey S, et al. Altered ubiquitin-proteasome signaling in right ventricular hypertrophy and failure. Am J Physiol Heart Circ Physiol (2013) 305(4):H551-62. doi:10.1152/ajpheart.00771.2012
84. Loukanov T, Jaschinski C, Kirilov M, Klimpel H, Karck M, Gorenflo M. Cyclooxygenase-2 expression in lung in patients with congenital heart malformations and pulmonary arterial hypertension. Thorac Cardiovasc Surg (2013) 61(4):307-11. doi:10.1055/s-0033-1337446
85. Schupp DJ, Huck BP, Sykora J, Flechtenmacher C, Gorenflo M, Koch A, et al. Right ventricular expression of extracellular matrix proteins, matrix-metalloproteinases, and their inhibitors over a period of 3 years after heart transplantation. Virchows Arch (2006) 448(2):184-94. doi:10.1007/s00428-005-0050-z
86. Walker LA, Walker JS, Glazier A, Brown DR, Stenmark KR, Buttrick PM. Biochemical and myofilament responses of the right ventricle to severe pulmonary hypertension. Am J Physiol Heart Circ Physiol (2011) 301(3):H832-40. doi:10.1152/ajpheart.00249.2011
87. Voelkel NF, Gomez-Arroyo J, Abbate A, Bogaard HJ, Nicolls MR. Pathobiology of pulmonary arterial hypertension and right ventricular failure. Eur Respir J (2012) 40(6):1555-65. doi:10.1183/09031936.00046612